title: Neuropsychological and behavioral effects of postnatal dexamethasone in extremely low birth weight preterm children at early school age.
abstract: OBJECTIVE
  To study postnatal dexamethasone treatment effects on cognitive, neuropsychological and behavioral functioning at early school age in preterm children.
  
  
  METHODS
  We recruited 222 children born between 1998 and 2003: 114 extremely low birth weight (<1000 g; 60 dexamethasone-treated; 54 untreated) and 108 term-born. Data were analyzed using multivariate methods.
  
  
  RESULTS
  Preterm performed below term-born on all measures. Dexamethasone-treated performed below dexamethasone-untreated in immediate visual memory, visual-motor integration, mathematical skill and motor dexterity. However, stepwise regression indicated that medical and sociodemographic factors other than dexamethasone contributed to preterm group differences.
  
  
  CONCLUSIONS
  Dexamethasone alone does not explain neurocognitive impairment in preterm children. Medical and sociodemographic factors (illness severity, male gender and parental education) are influential. Prospective longitudinal neuropsychological and behavioral study from preschool to school age that considers medical and sociodemographic variables will best address effects of dexamethasone exposure.
authors.affiliation: Fairfax Neonatal Associates, Inova Fairfax Hospital for Children, Falls Church, VA, USA.
authors.forename: K C
authors.initials: KC
authors.lastname: Crotty
authors.forename: M D
authors.initials: MD
authors.lastname: Ahronovich
authors.forename: I S
authors.initials: IS
authors.lastname: Baron
authors.forename: R
authors.initials: R
authors.lastname: Baker
authors.forename: K
authors.initials: K
authors.lastname: Erickson
authors.forename: F R
authors.initials: FR
authors.lastname: Litman
mesh_terms: D001724:Birth Weight; D001997:Bronchopulmonary Dysplasia / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002653:Child Behavior Disorders / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D015331:Cohort Studies; D002658:Developmental Disabilities / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D003907:Dexamethasone / Q000009:adverse effects* / Q000627:therapeutic use; D056344:Executive Function; D005260:Female; D005865:Gestational Age; D006801:Humans; D052577:Infant, Extremely Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D015999:Multivariate Analysis; D009483:Neuropsychological Tests; D011181:Postnatal Care / Q000379:methods; D011247:Pregnancy; D047928:Premature Birth; D012016:Reference Values; D012044:Regression Analysis; D012189:Retrospective Studies; D018570:Risk Assessment; D012959:Socioeconomic Factors; D047929:Term Birth
chemical_list: D003907:Dexamethasone